Members of Congress grilled Mylan CEO Heather Bresch with questions about the high price of EpiPens during her Wednesday hearing with the House Committee on Oversight and Government Reform, according ...
Outraged Republican and Democratic lawmakers on Wednesday grilled the head of pharmaceutical company Mylan about the significant cost increase of its life-saving EpiPens and the profits for a company ...
An advance copy of her remarks suggests Mylan CEO Heather Bresch plans to defend the price hike for the company’s EpiPen before Congress Wednesday. However, Ms. Bresch will acknowledge that the ...
The drug company is near an agreement to combine the division, which includes Viagra and Lipitor, with the pharmaceutical company Mylan. By Michael J. de la Merced and Katie Thomas “I’m concerned that ...
In a congressional hearing last week, Mylan chief executive Heather Bresch did not give an accurate number concerning how much the company made from a two-pack of EpiPens, according to The Washington ...
WASHINGTON — Despite a withering 4-plus hours of questioning by members of a congressional committee yesterday, Mylan CEO Heather Bresch did not give a direct answer as to why the company had ...
Republicans and Democrats on the House Oversight and Government Reform Committee are demanding more information about the profit margins of the company that produces EpiPens, after the company ...
Mylan shareholders prepare for Perrigo vote. © 2025 American City Business Journals. All rights reserved. Use of and/or registration on any portion of this site ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results